Keywords: genzyme, 1st-qtr, sales, expected, usa-based, biotechnology, major

Genzyme's 1st-qtr sales less than expected

Article | 01 May 2006

Print This

USA-based biotechnology major Genzyme has reported net income of $101.0 million, or $0.37 per share for the first three months of 2006, up ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in